Advertisement
Screener

INTENSITY THERAPEUTICS, INC. (INTS) ROA

INTENSITY THERAPEUTICS, INC. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • INTENSITY THERAPEUTICS, INC. roa for the quarter ending 2026-06-30 was -96.89%, a change of 186.20% year-over-year.
  • INTENSITY THERAPEUTICS, INC. roa for the quarter ending 2026-03-31 was -87.00%, a change of 402.79% year-over-year.
  • INTENSITY THERAPEUTICS, INC. roa for the quarter ending 2025-12-31 was -82.31%, a change of 257.82% year-over-year.
  • INTENSITY THERAPEUTICS, INC. roa for the quarter ending 2025-09-30 was -122.44%, a change of 189.45% year-over-year.
  • INTENSITY THERAPEUTICS, INC. roa for fiscal 2025 was -82.31%, a change of 257.82% from fiscal 2024.
  • INTENSITY THERAPEUTICS, INC. roa for fiscal 2024 was -340.12%, a change of -279.19% from fiscal 2023.
  • INTENSITY THERAPEUTICS, INC. roa for fiscal 2023 was -60.93%, a change of 370.60% from fiscal 2022.
  • INTENSITY THERAPEUTICS, INC. roa for fiscal 2022 was -431.53%.
Available history
2022-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-96.89%-$11.16M-$3.01M$11.52M
2026-03-31-87.00%-$10.69M-$2.43M$12.29M
2025-12-31-82.31%-$11.61M-$3.05M$14.1M
2025-09-30-122.44%-$11.74M-$2.67M$9.59M
2025-06-30-283.10%-$12.58M-$2.54M$4.44M
2025-03-31-489.79%-$15.01M-$3.35M$3.07M
2024-12-31-340.12%-$16.27M-$3.18M$4.78M
2024-09-30-311.89%-$16.26M-$3.51M$5.21M
2024-06-30-173.82%-$15.08M-$4.97M$8.67M
2024-03-31-111.26%-$13.81M-$4.60M$12.41M
2023-12-31-60.93%-$10.54M-$3.17M$17.3M
2023-09-30-52.79%-$8.88M-$2.33M$16.82M
2023-06-30-45.66%-$8.32M-$3.70M$18.23M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-82.31%-$11.61M$14.1M
2024-12-31-340.12%-$16.27M$4.78M
2023-12-31-60.93%-$10.54M$17.3M
2022-12-31-431.53%-$7.58M$1.76M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37